OracleBio’s Chief Operations Officer, Dr John Waller, recently joined Roland Linder on Scottish Development International’s What in the Life Sciences podcast.
During the podcast, Roland and John have a conversation about the field of Quantitative Digital Pathology. Listen to the podcast to hear John and Roland discuss:
- What exactly is Quantitative Digital Pathology?
- What are the main challenges in the field?
- Where is the field going?
- and more!
What in the Life Sciences: Quantitative Digital Pathology Podcast
Reasons to Work With OracleBio:
Data you can trust – We have thorough quality control procedures in place throughout our workflow to ensure the data we provide is of a high-quality standard
Latest technologies – We continually invest time and money into the latest software and techniques so you don’t need to
More from OracleBio:
Quantitative Image Analysis and GCP: Q&A Blog
OracleBio's recent GCP implementation was driven by Clinical Operations Manager, Alison Bigley. In this blog, Alison discusses why GCP is important, the current state of play with regulatory standards in image analysis and more...What is Good Clinical Practice and why...
OracleBio’s Path to GCP Image Analysis – Digital Pathology Place Podcast
OracleBio's Chief Scientific Officer, Lorcan Sherry, recently joined Aleksandra Zuraw on the Digital Pathology Place podcast. During the podcast, Aleks and Lorcan have a conversation about the history of OracleBio and the company's journey to GCP Image Analysis....
Improving Colorectal Cancer Prognosis Using Deep Learning
Currently, digital pathology is undergoing a revolution owing to recent developments in the field of artificial intelligence (AI). Tasks that were previously thought too complex for machine learning to be able to handle are now being accomplished and applied to great...
Find out more about our Software Capabilities
OracleBio's Quantitative Digital Pathology Services
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more